Daniel W, Adamus A, Melzacka M, Szymura J, Vetulani J
Naunyn Schmiedebergs Arch Pharmacol. 1981; 317(3):209-13.
PMID: 7322212
DOI: 10.1007/BF00503818.
Baumann P, Gaillard J, Gerber C, Bouras C
Psychopharmacology (Berl). 1984; 84(4):489-95.
PMID: 6441950
DOI: 10.1007/BF00431455.
Daniel W, Friebertshauser J, Steffen C
Naunyn Schmiedebergs Arch Pharmacol. 1984; 328(1):83-6.
PMID: 6440032
DOI: 10.1007/BF00496111.
OMalley K, Browning M, Stevenson I, Turnbull M
Eur J Clin Pharmacol. 1973; 6(2):102-6.
PMID: 4769693
DOI: 10.1007/BF00562435.
Staubli W, Schweizer W, Suter J, Hess R
Agents Actions. 1974; 4(5):391-403.
PMID: 4480448
DOI: 10.1007/BF01964942.
Bioavailability of hetacillin in rats after liver enzyme induction by various inducers with or without protein binding properties.
Couvaris M, Galanopoulou P, Karageorgiou C, Jalil H, Varonos D
Eur J Drug Metab Pharmacokinet. 1985; 10(1):27-32.
PMID: 4029217
DOI: 10.1007/BF03189694.
Metabolic interaction between imipramine and carbamazepine in vivo and in vitro in rats.
Daniel W, NETTER K
Naunyn Schmiedebergs Arch Pharmacol. 1988; 337(1):105-10.
PMID: 3368009
DOI: 10.1007/BF00169485.
Single-dose kinetics of the neuroleptic drug perazine in psychotic patients.
Breyer-Pfaff U, Nill K, Schied H, Gaertner H, Giedke H
Psychopharmacology (Berl). 1988; 95(3):374-7.
PMID: 2901127
DOI: 10.1007/BF00181950.
Effect of enzyme induction on bioavailability of hetacillin in patients treated with anticonvulsants and chlorpromazine.
Galanopoulou P, Karageorgiou C, Dimakopoulou K
Eur J Drug Metab Pharmacokinet. 1990; 15(1):15-8.
PMID: 2384113
DOI: 10.1007/BF03190122.
Alteration of cytochrome P-450 by prolonged administration of imipramine and/or lithium to rats.
Daniel W, NETTER K
Naunyn Schmiedebergs Arch Pharmacol. 1990; 342(2):234-40.
PMID: 2234106
DOI: 10.1007/BF00166970.
Pharmacokinetic interaction between carbamazepine and neuroleptics after combined prolonged treatment in rats.
Daniel W, Janczar L, Danek L, Legrum W, NETTER K
Naunyn Schmiedebergs Arch Pharmacol. 1992; 345(5):598-605.
PMID: 1356236
DOI: 10.1007/BF00168955.
Effect of long-term phenothiazine treatment on drug metabolism.
KOLAKOWSKA T, Franklin M, ALAPIN B
Br J Clin Pharmacol. 1975; 2(1):25-8.
PMID: 1234485
PMC: 1402496.
DOI: 10.1111/j.1365-2125.1975.tb00467.x.
Cyclobarbital as a test substance for oxidative drug metabolism in man. Findings in neuropsychiatric patients.
Breyer-Pfaff U, Jerg H, Petruch F
Eur J Clin Pharmacol. 1979; 15(6):433-41.
PMID: 40799
DOI: 10.1007/BF00561744.
Phenprocoumon requirement, whole blood coagulation time, bleeding time and plasma gamma-GT in patients receiving mianserin.
KOPERA H, Schenk H, Stulemeijer S
Eur J Clin Pharmacol. 1978; 13(5):351-6.
PMID: 27373
DOI: 10.1007/BF00644608.
Kinetics of 35S-perazine in the bile fistula rat.
BREYER U, Jahns I, IRMSCHER G, Rassner H, Rehmer S
Naunyn Schmiedebergs Arch Pharmacol. 1977; 300(1):47-56.
PMID: 22822
DOI: 10.1007/BF00505079.